Xiujuan Qu

8.3k citations
262 papers · 5.3k indexed · h-index 40
Topics
Cancer Immunotherapy and Biomarkers (30 papers)Lung Cancer Treatments and Mutations (27 papers)Gastric Cancer Management and Outcomes (26 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Xiujuan Qu

246 papers receiving 5.3k citations

Peers

Xiujuan Qu
Comparison fields: 5 of 121
  • Molecular Biology 3.2k
  • Oncology 1.9k
  • Cancer Research 1.7k
  • Pulmonary and Respiratory Medicine 884
  • Immunology 860
Replace Poornima Bhat‐Nakshatri with:
Poornima Bhat‐Nakshatri United States
Ranju Ralhan India
Benedito A. Carneiro United States
Lanxi Song United States
Valentina M. Factor United States
Franca Stivala Italy
Rongcheng Luo China
Jeong‐Seok Nam South Korea
Ralf Buettner United States
Zhi‐Ming Shao China
Xiujuan Qu relative to Poornima Bhat‐Nakshatri United States Poornima Bhat‐Nakshatri's profile →
Citations per field
00.5×
Poornima Bhat‐Nakshatri · 1×
Citations per year

Countries citing papers authored by Xiujuan Qu

Since Specialization
Citations

This map shows the geographic impact of Xiujuan Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiujuan Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiujuan Qu more than expected).

Fields of papers citing papers by Xiujuan Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiujuan Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiujuan Qu. The network helps show where Xiujuan Qu may publish in the future.

Co-authorship network of co-authors of Xiujuan Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiujuan Qu. A scholar is included among the top collaborators of Xiujuan Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiujuan Qu. Xiujuan Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 36
5 5
6 0
7 9
8 7
9 12
10 13
11 11
12 6
13 50
14 29
15 46
16 24
17 10
18 12
19 18
20 1

About Xiujuan Qu

Xiujuan Qu is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 262 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (30 papers), Lung Cancer Treatments and Mutations (27 papers) and Gastric Cancer Management and Outcomes (26 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (1.9k citations) and Molecular Biology (3.2k citations). Xiujuan Qu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yunpeng Liu, Kezuo Hou, Xiaofang Che, Ling Xu, Zhi Li, Ce Li, Yibo Fan, Yuee Teng, Jinglei Qu and Ye Zhang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026